CAS 849206-43-5

4H-Furo[3,4-d]imidazol-4-one, 3,6-dihydro-6,6-dimethyl-2-propyl-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]- 4-yl]methyl]-

Description:

4H-Furo[3,4-d]imidazol-4-one, 3,6-dihydro-6,6-dimethyl-2-propyl-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- is a complex organic compound characterized by its unique fused ring structure, which includes a furoimidazole moiety. This compound features multiple functional groups, including a tetrazole and biphenyl substituent, contributing to its potential biological activity. The presence of the dimethyl and propyl groups suggests hydrophobic characteristics, which may influence its solubility and interaction with biological membranes. The compound's structure indicates potential applications in medicinal chemistry, particularly in the development of pharmaceuticals, due to the presence of heterocycles that are often associated with bioactive compounds. Its CAS number, 849206-43-5, allows for precise identification in chemical databases. Overall, this compound exemplifies the complexity and diversity of organic molecules, with implications for research in drug design and development.

Formula: C₂₄H₂₄N₆O₂

Olmesartan Medoxomil Related Compound A (1-{[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol-6(4H)-one)

CAS: 849206-43-5

Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi

Formula: C₂₄H₂₄N₆O₂

Color and Shape: White Solid

Molecular weight: 428.49

Ref: 45-1478378

Olmesartan Lactone Impurity

CAS: 849206-43-5

Formula: C₂₄H₂₄N₆O₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 428.4864

Ref: IN-DA00G42E

Olmesartan lactone impurity

CAS: 849206-43-5

Olmesartan lactone impurity

Purity: ≥95%

Molecular weight: 428.49g/mol

Ref: 54-OR1005052

Olmesartan Medoxomil EP Impurity B (Olmesartan Medoxomil USP Related Compound A)

CAS: 849206-43-5

Formula: C₂₄H₂₄N₆O₂

Color and Shape: White To Off-White Solid

Molecular weight: 428.50

Ref: 4Z-O-0816

6,6-Dimethyl-2-propyl-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-3,6-dihydro-4H-furo[3,4-d]imidazol-4-one

Controlled Product

CAS: 849206-43-5

Formula: C₂₄H₂₄N₆O₂

Color and Shape: Neat

Molecular weight: 428.49

Ref: 86-MM1317.02

Olmesartan lactone impurity

CAS: 849206-43-5

Olmesartan lactone impurity, a cyclic ester from Olmesartan, aids in hypertension research as an AT1R blocker.

Formula: C₂₄H₂₄N₆O₂

Color and Shape: Solid

Molecular weight: 428.496

Ref: TM-T40941

Olmesartan lactone impurity

CAS: 849206-43-5

Molecular weight: 428.496

Ref: 10-F987295

Olmesartan Lactone Impurity

CAS: 849206-43-5

Impurity Olmesartan EP Impurity B/ Olmesartan Medoximil USP Related Compound A
Applications Olmesartan Lactone Impurity (Olmesartan EP Impurity B) is a cyclic ester impurity of Olmesartan (O550000).

Formula: C₂₄H₂₄N₆O₂

Color and Shape: White

Molecular weight: 428.49

Ref: TR-O550030

Olmesartan Medoxomil EP Impurity B

CAS: 849206-43-5

Formula: C₂₄H₂₄N₆O₂

Molecular weight: 428.5

Ref: ST-EA-CP-O7002

Olmesartan lactone impurity

CAS: 849206-43-5

Olmesartan lactone impurity is a high-purity, low-cost, and stable pharmaceutical intermediate. It is an ester of olmesartan and medoxomil. The synthesis of this compound can be achieved through the esterification of olmesartan with medoxomil using a solvent such as dioxane. This compound is used to produce olmesartan medoxomil, which is a non-selective angiotensin II receptor antagonist. Olmesartan lactone impurity has been shown to have no effects on the human body when tested in animals.

Formula: C₂₄H₂₄N₆O₂

Purity: Min. 95%

Color and Shape: White Powder

Molecular weight: 428.49 g/mol

Ref: 3D-ID57929